Give the gift of LIFE! Support the Population Research Institute!

Only $106,679 to go!

Topics: DMPA

Depo-Provera and HIV



Photo credit: ands456/Getty Images The Issue Injectable contraceptives like Depo-Provera increase the risk of HIV transmission. A recent meta-analysis conducted in collaboration with the Population Research Institute reviewed a total of 24 studies published in peer-reviewed journals and found a significant increased risk of acquiring HIV when using Depo-Provera and other injectables. Injectable contraceptives are commonly used worldwide, particularly in Sub-Saharan Africa where the prevalence of HIV remains high. International aid programs that are providing …

Read more.




a woman in thought

USAID Needs to Warn Women of the Dangers of Depo-Provera



  Despite mounting evidence of serious side effects associated with the use of injectable contraceptives, international aid programs continue to indiscriminately distribute Depo-Provera under various brand names worldwide. Indeed, a coalition of family planning partners including the United States Agency for International Development (USAID), the Bill and Melinda Gates Foundation, PATH (Program for Appropriate Technology in Health), and others are seeking to inject even more vulnerable women in developing countries with risky injectable contraceptives. Like …

Read more.




New Study Shows Risk of HIV Acquisition Is Higher with DMPA Contraceptives



A review and meta-analysis has found that women who use depot medroxyprogesterone acetate (DMPA), the active ingredient in injectable contraceptives like Depo-Provera, are placed at a significantly higher risk of acquiring HIV. The findings could have a deep residual impact for many women who depend on DMPA for contraception and are living in developing countries or in at-risk environments where the risk of HIV transmission remains high. Joel Brind, Professor of Biology and Endocrinology at …

Read more.




Never miss an update!

Get our Weekly Briefing! We send out a well-researched, in-depth article on a variety of topics once a week, to large and growing English-speaking and Spanish-speaking audiences.